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CORRESPONDENCE
Preliminary results of allograft use 
from the South African skin bank
To the Editor: In 2013, Rogers et al.[1] highlighted the desperate need 
for a skin bank in this country. Earlier this year, Allorto et al.,[2] in 
a letter to this journal, reported the establishment of South Africa 
(SA)’s first skin bank, and advocated for increased donation, as well 
medical and lay education to increase tissue donation to meet the 
enormous need.
The primary motivation for this initiative is to have a ready 
supply of deceased donor (cadaver) allograft for use as a biological 
temporary skin substitute. In the context of major burn injury, 
allograft is used as a temporary wound cover after excision of deep 
partial thickness and full thickness burns prior to autografting, or 
as physical protection and a scaffold over widely meshed autografts. 
Allograft is the best possible test of the capacity for a wound bed to 
accommodate subsequent autografting, especially in the context of a 
major burn with limited donor sites, but is also invaluable following 
the management of wound infection, necrosis or other conditions 
that may compromise take. Excellent results have also been reported 
in the context of exfoliative disorders of the skin or as part of 
reconstructive surgeries to create a dermal scaffold (referred to as 
alloderm or allodermis).
Burns exceeding 40% of the total body surface area (TBSA) 
have inadequate donor skin available to cover the excised burn 
eschar. Temporary alternatives to autografts include synthetic skin 
substitutes or deceased donor allograft. Allografts can be sourced 
from organ donor patients, hospital or state mortuaries, private 
institutions or (rarely) living donors. Using restrictive guidelines for 
its use, at least 25 patients per month with major burns would benefit 
from allograft use as part of their burn care in SA. The establishment 
of a national skin bank attached to the Tshwane University of 
Technology ensures the availability of a legal, secure and readily 
available source of quality allograft. The bank was officially opened 
in April 2016 and is supported by the Department of Health and the 
SA Tissue Bank (SAtiBA).
Similar to the European skin bank, allograft preservation is through 
an inexpensive process of glycerolisation. Once deglycerolised, the 
product functions as a valuable temporary skin cover, undergoing 
the phases of graft take not unlike autograft (plasmatic imbibition, 
inosculation and neovascularisation). Tissue compatibility between 
donor and recipient is not required, although rejection is inevitable 
if skin is left on for more than 2 weeks, resulting in epidermolysis. 
The skin is commercially available at R11/cm2 and can be stored for 
at least 2 years at 4°C.
We present our preliminary results from eight paediatric patients 
managed at the Red Cross War Memorial Children’s Hospital using 
glycerolised allografts obtained from the skin bank. The mean age 
was 3.6 years (range 10 months to 8 years). Seven sustained flame 
burns and one a deep scald injury. The indications for allograft use 
in all eight were cover following burn eschar excision and wound 
preparation, and to enhance epithelialisation after micrografting 
in five patients. The mean TBSA burn was 49% (range 11 - 86%). 
Allografts were placed immediately after early excision, typically on 
day 3 (range 1 - 9 days). Autograft take following allograft wound 
preparation was greater than 90% in all cases. The TBSA grafted 
with allograft in these eight children was 35.9%; this was a total of 
12 100 cm2 allograft. All the children survived and were discharged, 
following shorter average hospitals stays than before.
We used allograft to optimise wound bed preparation after 
excision, contributing to excellent outcomes after removal of the 
micrograft sheets on the seventh postoperative day. Having allograft 
available at both of these critical phases has undoubtedly resulted 
in shorter hospital lengths of stay (less than 1.5 days per percentage 
burn), and increased the lethal dose, 50% (LD50) of major burns in 
this unit to over 70% TBSA, a statistic unprecedented in low- and 
middle-income countries. Another paediatric burn unit in SA, 
Chris Hani Baragwanath Hospital, also started using skin bank 
allograft recently, where it was applied to four children with burns 
between 30 and 50% TBSA as part of temporary skin cover after 
initial excision.
The skin bank has changed the landscape for the management of 
major burns in SA.
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